Goldman Sachs Reiterates Neutral Rating on Regenxbio Inc. (RGNX)
Tweet Send to a Friend
Goldman Sachs analyst Paul Choi reiterated a Neutral rating and $14.00 price target on Regenxbio Inc. (NASDAQ: RGNX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
